Research & Development
18 March 2019 - - US-based Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI) has voluntarily withdrawn its Biologics License Application for Rolontis due to the US Food and Drug Administration's r...
18 March 2019 - - The US Food and Drug Administration has accepted for review the company's New Drug Application for its higher naloxone injection product candidate for the treatme...
18 March 2019 - Biotechnology company Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi on Friday jointly announced the receipt of approval from the European Commission (EC) for the new indicatio...
18 March 2019 - Regulus Therapeutics Inc (Nasdaq:RGLS) stated on Friday that Timothy Wright has stepped down as its chief research and development officer with immediate effect.Dr Wright has submitted...
18 March 2019 - RNAi therapeutics company OliX Pharmaceuticals Inc (Kosdaq:226950) reported on Monday that it plans to develop and commercialise OLX301A for treating both wet and dry AMD, under a lice...
15 March 2019 - - A Data Safety Monitoring Board has recommended the continuation of US-based biopharmaceutical company Soleno Therapeutics, Inc.'s (NASDAQ: SLNO) Phase III trial in Prader-Willi ...
Related Headlines